Simplifying Global Compliance
The QMN Weekly Bulletin
Pharmaceuticals / Regulatory Affairs / Inspections and Audits
Indian Hospira Plant Gets Extensive Form 483
Jan. 24, 2014
Sterile injectables maker Hospira was hit with a new Form 483 containing nearly two dozen observations after FDA investigators followed up an October 2012 inspection that uncovered inadequate sanitization procedures at its Irungattukottai, India, facility.
Drug GMP Report
Copyright ©2017. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing